Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal for Immunotherapy of Cancer|June 26, 2020
Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progressionEtienne Giroux Leprieur, Zofia Hélias-Rodzewicz, Paul Takam Kamga, et al.
Cancers|October 14, 2020
Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder CancerSophie Vacher, Voreak Suybeng, Elodie Girard, et al.
British Journal of Cancer|October 13, 2021
Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLCSimon Garinet, Audrey Didelot, Thomas Denize, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2024
STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT TASTE trialJean Baptiste Oudart, Simon Garinet, Caroline Leger, et al.
Journal of Medical Case Reports|April 23, 2021
Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case reportRosa Montero-Macias, Meriem Koual, Céline Crespel, et al.
Thyroid : Official Journal of the American Thyroid Association|February 16, 2022
Redifferentiating Effect of Larotrectinib in NTRK-Rearranged Advanced Radioactive-Iodine Refractory Thyroid CancerLionel Groussin, Hélène Theodon, Laura Bessiene, et al.
Clinics and Research in Hepatology and Gastroenterology|February 13, 2022
BRCA1 and RAD51C promotor methylation in human resectable pancreatic adenocarcinomaRaëf Abdallah, Shulin Zhao, Simon Garinet, et al.
Therapeutic Advances in Medical Oncology|November 20, 2025
Characteristics of KRAS WT pancreatic adenocarcinomas: results of a large French multicentric cohortNoémie Trystram, Jérome Cros, Hélène Blons, et al.
Lung Cancer (Amsterdam, Netherlands)|May 21, 2022
SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophilsYoan Velut, Elise Decroix, Hélène Blons, et al.
Pathology|June 4, 2024
Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practiceSimon Garinet, Audrey Lupo, Thomas Denize, et al.
Pageof 5